Study of Biomarkers in Neutropenic Patients with Sepsis
Author Information
Author(s): Brunna E. Alves, Silmara A. L. Montalvao, Francisco J. P. Aranha, Irene Lorand-Metze, Carmino A. De Souza, Joyce M. Annichino-Bizzacchi, Erich V. De Paula
Primary Institution: University of Campinas
Hypothesis
Can sFlt-1 and VEGF-A levels serve as biomarkers for sepsis severity in neutropenic patients?
Conclusion
sFlt-1 and VEGF-A levels are higher in neutropenic patients who develop septic shock compared to those with non-complicated sepsis.
Supporting Evidence
- Patients with septic shock had higher sFlt-1 and VEGF-A levels 48 hours after fever onset.
- sFlt-1 levels correlated with sepsis severity scores.
- The study suggests that sFlt-1 could be a compensatory mechanism in septic shock.
Takeaway
This study looked at two substances in the blood that might help doctors understand how sick a patient is when they have a serious infection after chemotherapy.
Methodology
The study measured sFlt-1 and VEGF-A levels in neutropenic patients at different time points and correlated these levels with sepsis severity.
Potential Biases
The study design may not reflect real-world conditions as it was conducted in a controlled hospital setting.
Limitations
The study had a relatively low number of patients and was conducted in a single center, which may limit the generalizability of the findings.
Participant Demographics
Patients were adults with hematological malignancies undergoing intensive chemotherapy.
Statistical Information
P-Value
p<0.01
Confidence Interval
0.73-1.00
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website